Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Sterling slips on deal flow bets; outlook bright

Tue, 27th Mar 2018 10:31

By Saikat Chatterjee and Tom Finn

LONDON, March 27 (Reuters) - Sterling fell nearly 1 percenton Tuesday and is on track to post its biggest daily loss in amonth as expectations of selling pressure from a large corporatehealthcare deal prompted investors to take profits after arecent rally.

The British currency enjoyed a strong last week afterBritain secured a Brexit transition deal with the EuropeanUnion, official data showed British workers' wages growing attheir fastest rate in nearly 2-1/2 years and the BoE confirmedits hawkish tilt.

Such has been the bullishness around the short-term outlookfor sterling that the British currency was trading near Brexitreferendum vote highs against most of its rivals, including theSwiss franc

But news that GlaxoSmithKline will buy Novartis's36.5 percent stake in their consumer healthcare jointventure for $13 billion in cash triggered an unwinding of longsterling bets against its rivals built up after Britain clinchedthe transition deal last week.

Sterling's fall against the franc rippled over into thebroader market complex with the pound falling 1 percent againstthe dollar and 0.5 percent against the euroas investors took profits before the typically volatile quarterend period.

"We have seen sterling come a long way over the last week so

the deal may well have been the triggerfor some profit taking," said Jane Foley, FX strategist atRabobank in London.

The British currency was down 0.5 percent against the Swissfranc at 1.3361 francs, its biggest drop since Feb. 8,according to Thomson Reuters data.

Against the dollar, sterling plunged nearly apercent but is still up more than 4 percent so far this year asinvestors snapped up the pound citing its undervaluationrelative to other currencies.

QUARTER-END FLOWS

Foley said a fall in the pound could also have been causedby quarterly flows as global asset and fund managers rebalancetheir portfolios, a move that can distort markets.

"There is a fair amount of sterling that has to be soldagainst the Swiss franc and we are at post-Brexit referendumvote highs," said John Marley, head of FX strategy at InfinityInternational, a currency risk management firm.

On a trade-weighted basket basis, the poundwas trading at two-month highs above 80.

A revival in risk appetite in the broader markets alsounderpinned sterling's gains in the previous session.

Global markets were shaken this month after U.S. PresidentDonald Trump moved to impose tariffs on Chinese goods andBeijing threatened similar measures, though headlines over thelast 24 hours suggested that tensions were receding.

Derivative markets were signalling bullishness for sterlingin the short term with three-month risk reversals for theBritish currency - a ratio of calls to puts --trading at their highest level in more than a month.

"While the attraction of the euro in part reflects itsstructural large current account surplus, the pound isbenefiting more from expectations of positive cyclicaldevelopments," MUFG strategists wrote in a daily note.

(Editing by Mark Heinrich)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.